Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Therapeutic Indication
Methylene Blue Market Projected to Reach USD 124 Million by 2034 at 5.0% CAGR
Methylene Blue Market Projected to Reach USD 124 Million by 2034 at 5.0% CAGR Author : jenny kay | Published On : 02 Nov 2026 Market Overview The global Methylene Blue Market is witnessing steady expansion as the compound continues to serve important functions across pharmaceutical applications, clinical diagnostics, aquaculture health management, and biomedical research.
Omalizumab Biosimilars Market: $747M by 2034, 12.2% CAGR
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding.
United States Botanical Drugs Market Size, 2034
(MENAFN- Straits Research) United States Botanical Drugs Market Size The United States botanical drugs market size was valued at USD 1.84 billion in 2025 and is projected to grow from USD 2.02 billion in 2026 to reach USD 4.32 billion by 2034, growing at a CAGR of 9.95% during the forecast period 2026–2034.
Pharmaceutical Regulatory Affairs Market Size, Trends, Growth Factors, Analysis and Forecast 2026-2034
The pharmaceutical regulatory affairs market has demonstrated steady growth, reflecting pharmaceutical companies' increasing reliance on specialized expertise to navigate complex global regulatory environments. According to IMARC Group, the global pharmaceutical regulatory affairs market size reached USD 10.6 Billion in 2025 and is projected to reach USD 21.2 Billion by 2034, exhibiting a CAGR of 7.78% during 2026-2034.
Global mRNA Cancer Vaccines Market Opportunity, Therapeutic Development Proprietary Technologies & Clinical Trials Insight 2026
Global mRNA Cancer Vaccines Market Opportunity, Therapeutics Development Proprietary Technologies & Clinical Trials Insight 2026 Report Findings & Highlights: Market Trends By Region & Therapeutic Indication First mRNA Cancer Vaccine Commercial Availability Expected By 2031 Insight On mRNA Cancer Vaccines In Clinical Trials: > 70 Vaccines Highest Clinical Phase Of Development: Phase-III Key mRNA Cancer Vaccine Clinical Timeline Insights Global mRNA Cancer Vaccine Clinical Trials Insight By...
Citicoline Market Size, Share, Growth, Analysis, Forecast, 2034
(MENAFN- Straits Research) Citicoline Market Size & Growth Analysis The citicoline market size was valued at USD 892.08 million in 2025 and is projected to grow from USD 958.99 million in 2026 to USD 1,732.79 million by 2034 at a CAGR of 7.68% during the forecast period (2026–2034). North America accounted for the largest citicoline market share of 37.20% in 2025.
Blood Plasma Market, By Product, By Application, By Therapeutic Indication, By End User, By Geography
Blood Plasma Market is estimated to be valued at USD 43.1 Mn in 2026 and is expected to reach USD 89.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.
Intravenous To Subcutaneous Drug Repositioning Market Size, Share & Growth Graph By 2034
(MENAFN- Straits Research) Intravenous to Subcutaneous Drug Repositioning Market Size The intravenous to subcutaneous drug repositioning market size was valued at USD 35.87 billion in 2025 and is projected to grow from USD 38.45 billion in 2026 to USD 68.71 billion by 2034 at a CAGR of 7.53% during the forecast period (2026-2034), as per Straits Research Analysis.
Proton Pump Inhibitors (PPI) Market Forecast at US$ 5.8 Bn by 2033: Persistence Market Research
proton pump inhibitors (PPI) market Overview of the proton pump inhibitors market, highlighting key trends, drivers, challenges, and growth opportunities across regions and segments. LONDON, UNITED KINGDOM, March 23, 2026 /EINPresswire.com/ -- The global proton pump inhibitors (PPI) market is projected to reach US$ 3.9 billion in 2026 and expand to US$ 5.8 billion by 2033, registering a compound annual growth rate (CAGR) of 5.8% during the forecast period.
Proton Pump Inhibitors (PPI) Market Forecast At US$ 5.8 Bn By 2033: Persistence Market Research
(MENAFN- EIN Presswire) EINPresswire/ -- The global proton pump inhibitors (PPI) market is projected to reach US$ 3.9 billion in 2026 and expand to US$ 5.8 billion by 2033, registering a compound annual growth rate (CAGR) of 5.8% during the forecast period. This steady growth is primarily driven by rising patient volumes, increased reliance on long-term maintenance therapy, and expanding over-the-counter (OTC) availability.
Proton Pump Inhibitors (PPI) Market Grows at 6% CAGR Through 2033 | Persistence Market Research
Proton Pump Inhibitors (PPI) Market Global Proton Pump Inhibitors market overview highlighting trends, growth drivers, therapeutic use, regional dynamics, and competitive landscape insights. LONDON, UNITED KINGDOM, January 27, 2026 /EINPresswire.com/ -- The global Proton Pump Inhibitors (PPI) market is entering a phase of stable, volume-driven growth, underpinned by rising gastrointestinal disease burden, expanding over-the-counter (OTC) availability, and strong demand from emerging economies.
Wireless Polysomnography Market Size Forecast by Product 2034
Forum Diskusi dan Komunitas Online / international zone / Article / Wireless Polysomnography Market Size Forecast by Product 2034 Thread Rating: 0 Vote(s) - 0 Average 1 2 3 4 5 Wireless Polysomnography Market Size Forecast by Product 2034 Inside this study, you will find a clear analysis of the global wireless polysomnography market with projections through 2034. It explains future market size estimates and the growth rate over the forecast period.
Insulin Analog Market Forecasting USD 25.29 Billion Valuation by 2034
The global insulin analog market size was valued at USD 16.99 billion in 2024 and is predicted to hit around USD 25.29 billion by 2034, rising at a 4.06% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Dec.
Insulin Analog Market Forecasting USD 25.29 Billion Valuation by 2034 - Business Upturn
The global insulin analog market size was valued at USD 16.99 billion in 2024 and is predicted to hit around USD 25.29 billion by 2034, rising at a 4.06% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Dec.
Insulin Analog Market Forecasting USD 25.29 Billion Valuation By 2034
(MENAFN- GlobeNewsWire - Nasdaq) The global insulin analog market size was valued at USD 16.99 billion in 2024 and is predicted to hit around USD 25.29 billion by 2034, rising at a 4.06% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Dec.
DNA Damaging Agents Market Grows at 11.67% CAGR, to Hit USD 46.31 Billion by 2034 - Business Upturn
The global DNA damaging agents market size was valued at USD 15.33 billion in 2024 and is predicted to hit around USD 46.31 billion by 2034, rising at a 11.67% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Nov. 26, 2025 (GLOBE NEWSWIRE) — The global DNA damaging agents market size is calculated at USD 17.12 billion in 2025 and is expected to reach around USD 46.31 billion by 2034, growing at a CAGR of 11.67% for the forecasted period.
Psychedelic Drugs Market - Global Psychedelic Drugs Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Therapeutic Indication, By Route of Administration, By Origin, By Geographic Coverage and By Company)
The global Psychedelic Drugs Market is witnessing significant momentum, valued at approximately USD 4.1 billion in 2025 and projected to reach around USD 9.5 billion by 2032, growing at a robust CAGR of 12.9%. This growth is largely driven by expanding research in mental health disorders, evolving regulatory frameworks, and increasing investment in psychedelic-assisted therapies across key global markets.
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034
Description RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down. Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035
Description The global targeted protein degradation market is projected to reach USD 9.85 billion by 2035 from an estimated USD 0.48 billion in 2025, at a CAGR of 35.4% from 2025 to 2035. The expansion of the targeted protein degradation market has been predominantly fueled by Capital inflows & big-pharma tie-ups, and multi-indication expansion. However, CMC & scale-up complexity for heterobifunctional and IP disputes are expected to restrain market growth.
Targeted Protein Degradation Market Growth, Drivers, and Opportunities
Home Pharmaceuticals Targeted Protein Degradation Market Report Code PH 9483 Published in Aug, 2025, By MarketsandMarkets™ Download PDF Choose License Type Inquire Before Buying Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035 Overview The targeted protein degradation market is projected to reach...
Global Oral Proteins and Peptides Assessment, By Active Ingredient, By Formulation Type, By Delivery Technology, By Therapeutic Indication, By Region, Opportunities and Forecast, 2018-2032F
Global oral proteins and peptides market is projected to witness a CAGR of 13.66% during the forecast period 2025-2032, growing from USD 6.67 billion in 2024 to USD 18.58 billion in 2032. Oral proteins and peptides are therapeutic biomolecules taken through the mouth in the form of tablets and capsules instead of injections.
Blood Plasma Market, By Product, By Application, By Therapeutic Indication, By End User, By Geography
Global Blood Plasma Market is estimated to be valued at USD 38.8 Mn in 2025 and is expected to reach USD 79.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032.
Global Anti-Fungal Treatment Market Size is Estimated to Original
New York, United States, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Pharmaceutical fungicides, also known as fungistatic anti-fungal or antimycotics, are used to treat and prevent mycosis, including, but not limited to, ringworm, candidiasis, and cryptococcal meningitis. Fungal infections also provide a severe risk to people with compromised immune systems, such as AIDS patients. There are numerous anti-fungal medications available to treat fungal infections.
Global Anti-Fungal Treatment Market Size Is Estimated To Reach USD 33,305.42 Million By 2031, Growing At A CAGR Of 6.45%: Straits Research
(MENAFN- GlobeNewsWire - Nasdaq) The Americas, holding a dominant 40.97% market share, are expected to grow at a notable CAGR of 6.47% during the forecast period. This growth is driven by the region's high prevalence of anti-fungal diseases, substantial research investments, and rapid adoption of advanced treatment modalities. New York, United States, Feb.
Wireless Polysomnography Market Size, Share, Growth Opportunity & Global Forecast To 2030
Free Press Release DB | Press Release Date : Oct 21, 2023 Download COVID-19 Impact Analysis on Wireless Polysomnography Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2030.
Blood Plasma Market is poised to grow at USD 63.33 Million Original
SAN FRANCISCO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research titled “Blood Plasma Market” with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand detailed analysis. The Blood Plasma Market research report has been produced by including highly developed insight and analysis which furnishes maximum benefits to the Blood Plasma industry.
Classified in: Health, Science and technology, Covid-19 virus Subject: MRR PUNE, India, March 8, 2022 /PRNewswire/ -- According to the report published by Absolute Markets Insights, the global RNA-targeted small molecules market is projected to grow at a CAGR of 6.1% during the forecast period (2021 ? 2029). Increased development of genome mapping programs, increased innovative developments, and increased applications are driving the global RNA-targeted small molecules market.
Global Ophthalmic Telemedicine Market to grow at a CAGR of 10.5% during 2022 Original
PUNE, India, March 8, 2022 /PRNewswire/ -- According to the newly published report by Absolute Markets Insights, the global ophthalmic telemedicine market is anticipated to register a CAGR of 10.5% over the period of next eight years (2022 - 2030).
Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market
- Global Biomarkers Market Forecast to 2029 - Consumables, Services, Software, Biomarker Discovery, Biomarker Diagnostics, Biomarker Services, Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS Diseases, Autoimmune Diseases LONDON, Dec. 4, 2019 /PRNewswire/ -- The global biomarkers market is expected to grow at a CAGR of 9.9% in the first half of the forecast period.
Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market
- Global Biomarkers Market Forecast to 2029 - Consumables, Services, Software, Biomarker Discovery, Biomarker Diagnostics, Biomarker Services, Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS Diseases, Autoimmune Diseases LONDON, Dec. 4, 2019 /PRNewswire/ -- The global biomarkers market is expected to grow at a CAGR of 9.9% in the first half of the forecast period.
Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market
- Global Biomarkers Market Forecast to 2029 - Consumables, Services, Software, Biomarker Discovery, Biomarker Diagnostics, Biomarker Services, Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS Diseases, Autoimmune Diseases LONDON, Dec. 4, 2019 /PRNewswire/ -- The global biomarkers market is expected to grow at a CAGR of 9.9% in the first half of the forecast period.
Global Anti-fungal Drugs Market Growth and Trends to 2023 - Analysis by Drug Type, Therapeutic Indication, and Geography - ResearchAndMarkets.com
The global anti-fungal drugs market is expected to register a CAGR of 3.6% during the forecast period, 2018 to 2023.With rising popularity of Over-The-Counter (OTC) drugs, many patients are preferring OTC drugs because these over the counter drugs are obtaining without a prescription from a healthcare professional. Numerous common and harmless fungal infections are left untreated by patients, owing to medical costs and logistical constraints.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Therapeutic
Contact Therapeutic, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack